RPL30 was increased in EAT-MI (P = 0.8975), EAT-CABG (P = 0.9995) and EAT-HL (P = 0.5641) groups compared to the control; however, the alterations among the groups were statistically not significant (Fig. 3b-I and b-II). Here, RPL30 is linked to myocardial infarction.